Raymond James Financial
XCUR icon

Raymond James Financial’s Exicure XCUR Stock Holding History

Raymond James Financial’s Portfolio XCUR Stock Details XCUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$49 – 6805
2025
Q2 		$49 Buy
+7
New +$71 ﹤0.01% 6886

Other funds holding XCUR

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Raymond James Financial's XCUR Position: Q3 2025 in Review

Raymond James Financial sold out of Exicure (XCUR) in Q3 2025, closing a stake of 7 shares — an estimated $49 sold.

Raymond James Financial first reported a position in XCUR in Q2 2025 and held it in 1 quarter. The position peaked at $49 in Q2 2025. 12 funds tracked by Wall St. Rank hold XCUR as of Q3 2025.

  • Raymond James Financial reported no remaining Exicure position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 7 Exicure shares in Q3 2025, an estimated $49.
  • Raymond James Financial first reported a position in Exicure in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Exicure position peaked at $49 in Q2 2025.
  • 12 funds tracked by Wall St. Rank held Exicure as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.